vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Limbach Holdings, Inc. (LMB). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $186.9M, roughly 1.1× Limbach Holdings, Inc.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 6.6%, a 1.7% gap on every dollar of revenue. On growth, Limbach Holdings, Inc. posted the faster year-over-year revenue change (30.1% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $27.9M). Over the past eight quarters, Limbach Holdings, Inc.'s revenue compounded faster (25.3% CAGR vs 19.1%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Limbach Flugmotoren is a Chinese-owned company based in Germany that produces aircraft engines.

COLL vs LMB — Head-to-Head

Bigger by revenue
COLL
COLL
1.1× larger
COLL
$205.4M
$186.9M
LMB
Growing faster (revenue YoY)
LMB
LMB
+17.2% gap
LMB
30.1%
12.9%
COLL
Higher net margin
COLL
COLL
1.7% more per $
COLL
8.3%
6.6%
LMB
More free cash flow
COLL
COLL
$94.5M more FCF
COLL
$122.4M
$27.9M
LMB
Faster 2-yr revenue CAGR
LMB
LMB
Annualised
LMB
25.3%
19.1%
COLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
LMB
LMB
Revenue
$205.4M
$186.9M
Net Profit
$17.0M
$12.3M
Gross Margin
62.5%
25.7%
Operating Margin
29.6%
9.4%
Net Margin
8.3%
6.6%
Revenue YoY
12.9%
30.1%
Net Profit YoY
35.3%
25.0%
EPS (diluted)
$0.48
$1.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
LMB
LMB
Q4 25
$205.4M
$186.9M
Q3 25
$209.4M
$184.6M
Q2 25
$188.0M
$142.2M
Q1 25
$177.8M
$133.1M
Q4 24
$181.9M
$143.7M
Q3 24
$159.3M
$133.9M
Q2 24
$145.3M
$122.2M
Q1 24
$144.9M
$119.0M
Net Profit
COLL
COLL
LMB
LMB
Q4 25
$17.0M
$12.3M
Q3 25
$31.5M
$8.8M
Q2 25
$12.0M
$7.8M
Q1 25
$2.4M
$10.2M
Q4 24
$12.5M
$9.8M
Q3 24
$9.3M
$7.5M
Q2 24
$19.6M
$6.0M
Q1 24
$27.7M
$7.6M
Gross Margin
COLL
COLL
LMB
LMB
Q4 25
62.5%
25.7%
Q3 25
61.7%
24.2%
Q2 25
57.7%
28.0%
Q1 25
54.8%
27.6%
Q4 24
54.0%
30.3%
Q3 24
60.8%
27.0%
Q2 24
62.5%
27.4%
Q1 24
63.1%
26.1%
Operating Margin
COLL
COLL
LMB
LMB
Q4 25
29.6%
9.4%
Q3 25
29.7%
7.2%
Q2 25
18.7%
7.5%
Q1 25
12.2%
5.9%
Q4 24
20.9%
9.1%
Q3 24
21.9%
8.1%
Q2 24
32.7%
6.7%
Q1 24
34.1%
5.5%
Net Margin
COLL
COLL
LMB
LMB
Q4 25
8.3%
6.6%
Q3 25
15.0%
4.8%
Q2 25
6.4%
5.5%
Q1 25
1.4%
7.7%
Q4 24
6.9%
6.9%
Q3 24
5.9%
5.6%
Q2 24
13.5%
4.9%
Q1 24
19.1%
6.4%
EPS (diluted)
COLL
COLL
LMB
LMB
Q4 25
$0.48
$1.01
Q3 25
$0.84
$0.73
Q2 25
$0.34
$0.64
Q1 25
$0.07
$0.85
Q4 24
$0.36
$0.81
Q3 24
$0.27
$0.62
Q2 24
$0.52
$0.50
Q1 24
$0.71
$0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
LMB
LMB
Cash + ST InvestmentsLiquidity on hand
$386.7M
$11.3M
Total DebtLower is stronger
$30.5M
Stockholders' EquityBook value
$301.7M
$195.7M
Total Assets
$1.7B
$381.1M
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
LMB
LMB
Q4 25
$386.7M
$11.3M
Q3 25
$285.9M
$9.8M
Q2 25
$222.2M
$38.9M
Q1 25
$197.8M
$38.1M
Q4 24
$162.8M
$44.9M
Q3 24
$120.0M
$51.2M
Q2 24
$271.6M
$59.5M
Q1 24
$318.0M
$48.2M
Total Debt
COLL
COLL
LMB
LMB
Q4 25
$30.5M
Q3 25
$56.3M
Q2 25
$28.4M
Q1 25
$23.7M
Q4 24
$23.6M
Q3 24
$20.5M
Q2 24
$19.7M
Q1 24
$19.4M
Stockholders' Equity
COLL
COLL
LMB
LMB
Q4 25
$301.7M
$195.7M
Q3 25
$274.8M
$181.6M
Q2 25
$232.2M
$170.5M
Q1 25
$234.4M
$161.1M
Q4 24
$228.8M
$153.5M
Q3 24
$234.3M
$142.2M
Q2 24
$216.6M
$133.0M
Q1 24
$222.2M
$125.5M
Total Assets
COLL
COLL
LMB
LMB
Q4 25
$1.7B
$381.1M
Q3 25
$1.6B
$409.1M
Q2 25
$1.6B
$343.0M
Q1 25
$1.6B
$336.4M
Q4 24
$1.7B
$352.1M
Q3 24
$1.6B
$324.4M
Q2 24
$1.1B
$303.9M
Q1 24
$1.1B
$289.2M
Debt / Equity
COLL
COLL
LMB
LMB
Q4 25
0.16×
Q3 25
0.31×
Q2 25
0.17×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.14×
Q2 24
0.15×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
LMB
LMB
Operating Cash FlowLast quarter
$123.0M
$28.1M
Free Cash FlowOCF − Capex
$122.4M
$27.9M
FCF MarginFCF / Revenue
59.6%
14.9%
Capex IntensityCapex / Revenue
0.3%
0.1%
Cash ConversionOCF / Net Profit
7.25×
2.29×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$41.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
LMB
LMB
Q4 25
$123.0M
$28.1M
Q3 25
$78.4M
$13.3M
Q2 25
$72.4M
$2.0M
Q1 25
$55.4M
$2.2M
Q4 24
$84.6M
$19.3M
Q3 24
$-9.0M
$4.9M
Q2 24
$67.4M
$16.5M
Q1 24
$61.9M
$-3.9M
Free Cash Flow
COLL
COLL
LMB
LMB
Q4 25
$122.4M
$27.9M
Q3 25
$78.3M
$12.8M
Q2 25
$72.4M
$1.2M
Q1 25
$54.6M
$11.0K
Q4 24
$84.1M
$18.0M
Q3 24
$-9.2M
$4.6M
Q2 24
$67.1M
$13.2M
Q1 24
$61.4M
$-6.5M
FCF Margin
COLL
COLL
LMB
LMB
Q4 25
59.6%
14.9%
Q3 25
37.4%
7.0%
Q2 25
38.5%
0.8%
Q1 25
30.7%
0.0%
Q4 24
46.2%
12.5%
Q3 24
-5.8%
3.4%
Q2 24
46.2%
10.8%
Q1 24
42.3%
-5.5%
Capex Intensity
COLL
COLL
LMB
LMB
Q4 25
0.3%
0.1%
Q3 25
0.1%
0.3%
Q2 25
0.0%
0.6%
Q1 25
0.4%
1.7%
Q4 24
0.3%
0.9%
Q3 24
0.2%
0.3%
Q2 24
0.2%
2.7%
Q1 24
0.4%
2.1%
Cash Conversion
COLL
COLL
LMB
LMB
Q4 25
7.25×
2.29×
Q3 25
2.49×
1.52×
Q2 25
6.05×
0.26×
Q1 25
22.92×
0.22×
Q4 24
6.75×
1.96×
Q3 24
-0.96×
0.66×
Q2 24
3.44×
2.77×
Q1 24
2.23×
-0.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

LMB
LMB

Owner Direct Relationships Segment$145.0M78%
General Contractor Construction Manager Relationships Segment$41.9M22%

Related Comparisons